SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,801.23 -156.04
( -0.20%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9540829

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

146.54

97240.21

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.69

Back

NCC consolidated net profit rises 12.63% in the June 2026 quarter

Aug 07,2026

Net profit of NCC rose 12.63% to Rs 216.40 crore in the quarter ended June 2026 as against Rs 192.14 crore during the previous quarter ended June 2025. Sales rose 12.22% to Rs 5811.83 crore in the quarter ended June 2026 as against Rs 5178.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5811.83	5178.99	12
OPM %	9.38	8.81	-
PBDT	380.95	323.40	18
PBT	311.64	268.36	16
NP	216.40	192.14	13

76,801.23 -156.04 ( -0.20%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,147.06 -258.50 (-0.39%)

10,824.26 31.76 (0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)